The New York Entrepreneur

McKesson to acquire controlling stake in Core Ventures for $2.49 billion in cash

Read Time:6 Second

McKesson said it hopes to “bring advanced treatments and improved care experiences to patients, while also reducing the overall cost of care.”

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post U.S. durable goods rise moderately in July — excluding volatile transportation sector
Next post SolarEdge’s stock surges as CEO steps down after 5 years in the role